Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, October 25 '25)

Image
By G.M.

 


    Br J Anaesth

  1. THOMAS C, Pearse RM
    Socioeconomic deprivation and health inequity: independently associated with postoperative outcomes, and does this matter?
    Br J Anaesth. 2025;135:1141-1143.
    PubMed         Abstract available


    Clin Infect Dis

  2. TARTOF SY, Aliabadi N, Goodwin G, Slezak J, et al
    Estimated Vaccine Effectiveness for Respiratory Syncytial Virus-Related Acute Respiratory Illness in Older Adults: Findings From the First Postlicensure Season.
    Clin Infect Dis. 2025 Oct 21:ciaf496. doi: 10.1093.
    PubMed         Abstract available

  3. MANABE YC, Hamill MM, Palamountain KM, Achenbach CJ, et al
    The Critical Importance of Clinical Use Case to Inform Point-of-Care Technology Development: A Case Study of Human Immunodeficiency Virus Nucleic Acid Assays in the United States.
    Clin Infect Dis. 2025 Oct 23:ciaf510. doi: 10.1093.
    PubMed         Abstract available


    Graefes Arch Clin Exp Ophthalmol

  4. LV Y, Zhu L, Li FH, Li H, et al
    Nonadherence to anti-VEGF intravitreal injections in patients with diabetic macular edema : The names of the authors.
    Graefes Arch Clin Exp Ophthalmol. 2025 Oct 18. doi: 10.1007/s00417-025-06925.
    PubMed         Abstract available


    Int J Infect Dis

  5. GENTILOTTI E, Gorska A, Tacconelli E
    Research on post-COVID syndrome: current gaps and future perspectives.
    Int J Infect Dis. 2025 Oct 16:108129. doi: 10.1016/j.ijid.2025.108129.
    PubMed         Abstract available

  6. DEB D, Heidari ME, Kizito B, Kesamang M, et al
    HIV status is not associated with SARS-CoV-2 viral load and longer duration of infection among people with well-controlled HIV and high COVID-19 vaccine coverage.
    Int J Infect Dis. 2025 Oct 17:108142. doi: 10.1016/j.ijid.2025.108142.
    PubMed         Abstract available

  7. OH J, Kim S, Jo H, Park J, et al
    Burden of post-acute sequelae of COVID-19 in patients with type 2 diabetes: a binational cohort study in South Korea and Japan.
    Int J Infect Dis. 2025 Oct 18:108143. doi: 10.1016/j.ijid.2025.108143.
    PubMed         Abstract available

  8. CARVALHO-SAUER R, Costa MDCN, Flores-Ortiz R, Teixeira MG, et al
    Case Fatality Rate and Determinants of Maternal Death among Pregnant Women with SARS-CoV-2 Infection: A Population-Based Cohort Study in Bahia, Brazil.
    Int J Infect Dis. 2025 Oct 20:108144. doi: 10.1016/j.ijid.2025.108144.
    PubMed         Abstract available

  9. DIAZ Y, Ortiz A, Weeden A, Castillo D, et al
    Corrigendum to "SARS-CoV-2 reinfection with a virus harboring mutation in the Spike and the Nucleocapsid proteins in Panama", [International Journal of Infectious Diseases, 108 (2021), 588-591, https://doi.org/10.1016/j.ijid.2021.06.004].
    Int J Infect Dis. 2025;161:108124.
    PubMed        


    Invest Radiol

  10. KUBLER J, Chekan S, Xu S, Ghoul A, et al
    Clinical Evaluation of A-LIKNet: Deep Learning-Accelerated Single-Breath-Hold CINE Magnetic Resonance Imaging for Cardiac Function Assessment.
    Invest Radiol. 2025 Oct 17. doi: 10.1097/RLI.0000000000001243.
    PubMed         Abstract available


    J Infect

  11. BORROW R, Caugant DA, Clark SA, Dinleyici EC, et al
    Current global trends in meningococcal disease control, risk groups and vaccination: Consensus of the Global Meningococcal Initiative.
    J Infect. 2025 Oct 17:106635. doi: 10.1016/j.jinf.2025.106635.
    PubMed         Abstract available


    J Med Virol

  12. SANDER I, Kespohl S, Beine A, Belting K, et al
    SARS-CoV-2 Antibody Levels and Infections in Multiple Vaccinated Employees Over Time.
    J Med Virol. 2025;97:e70628.
    PubMed         Abstract available

  13. BARTOLUCCI G, Garro E, Mussa M, Pepe A, et al
    The Clinical Presentations of Patients With COVID-19 in the Omicron Era: Missed Opportunities in the Antiviral Treatment of SARS-CoV-2 Infections.
    J Med Virol. 2025;97:e70652.
    PubMed         Abstract available

  14. ZHU M, Massuda E, Patel U, Chau G, et al
    Detection of Anti-SARS-CoV-2 Mucosal Immunoglobulin A in Clinical Saliva Samples After a Dose of Novavax COVID-19 Vaccine.
    J Med Virol. 2025;97:e70645.
    PubMed         Abstract available

  15. YEN TY, Hsu CL, Lu CY, Lee NC, et al
    The Association of RNase L, Cytokines, and Chemokines With Severity of Multisystem Inflammatory Syndrome in Children.
    J Med Virol. 2025;97:e70650.
    PubMed         Abstract available

  16. PATRICK MD, Foster A, Aneja A, Annamalai RT, et al
    Sexual Dimorphism in Systemic Inflammatory Responses to Femur Fracture in Mice Infected With SARS-CoV-2-Like Virus.
    J Med Virol. 2025;97:e70654.
    PubMed         Abstract available

  17. WONG CI, Zheng Y, Chen Y, Tsai YT, et al
    Viral Epidemiology and Etiology of Acute Respiratory Infections Among Hospitalized Pediatric Patients in Macao Across the Pre-, Peri-, and Post-COVID-19 Era.
    J Med Virol. 2025;97:e70664.
    PubMed         Abstract available

  18. GOSERT R, Naegele K, Weiss M, Bingisser R, et al
    Rebound of Respiratory Virus Activity and Seasonality to Pre-Pandemic Patterns.
    J Med Virol. 2025;97:e70658.
    PubMed         Abstract available

  19. LAI A, Bergna A, Fabiano V, Della Ventura C, et al
    Respiratory Syncytial Virus (RSV) in an Italian Pediatric Cohort: Genomic Analysis and Circulation Pattern in the Season 2022-2023.
    J Med Virol. 2025;97:e70660.
    PubMed         Abstract available

  20. HIKMAT H, Py J, Boschi C, Burel E, et al
    Implementation of a Multiplex PCR Amplification System Combined With Next-Generation Genome Sequencing to Decipher the Circulation of Human Coronavirus 229E Lineages in Southern France.
    J Med Virol. 2025;97:e70653.
    PubMed         Abstract available


    J Virol

  21. ZHOU J, Cai S, Huang H, Yang F, et al
    LPS/TLR4-activated M1-polarized macrophage-derived exosomes enhance IBV vaccine efficacy in chickens.
    J Virol. 2025 Sep 23:e0115625. doi: 10.1128/jvi.01156.
    PubMed         Abstract available

  22. DANGI T, Li S, Penaloza-MacMaster P
    Development of a cross-protective common cold coronavirus vaccine.
    J Virol. 2025 Oct 22:e0152625. doi: 10.1128/jvi.01526.
    PubMed         Abstract available


    Nature

  23. KOZLOV M
    People with some cancers live longer after a COVID vaccine.
    Nature. 2025 Oct 22. doi: 10.1038/d41586-025-03432.
    PubMed        

  24. GRIPPIN AJ, Marconi C, Copling S, Li N, et al
    SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade.
    Nature. 2025 Oct 22. doi: 10.1038/s41586-025-09655.
    PubMed         Abstract available


    Science

  25. CAPLAN A
    Vaccinations for allFair Doses Seth Berkley University of California Press, 2025. 408 pp.
    Science. 2025;390:342.
    PubMed         Abstract available

  26. JACOBS P
    COVID-19 vaccines may boost cancer immunotherapy.
    Science. 2025;390:321-322.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »